Latest Morning Briefing Stories

Possible Mass Exodus Brewing At Gilead As Another Top Official Announces Departure

KHN Morning Briefing

The moves add to growing investor unease over the health of large biotech companies, which are being pushed to find successors for aging blockbuster drugs. In other pharmaceutical news: Pfizer invests in a better flu vaccine; a startup struggles to build interest by male doctors for a drug that benefits women; and a deeper look at CAR-T therapy.

‘Deficiencies Persist’ In Government’s Treatment Of Migrant Children, Bipartisan Senate Report Finds

KHN Morning Briefing

The report faults the government for not having a single agency that is taking responsibility for the safety of the children, which makes them vulnerable to abuse and human trafficking. Agencies fired back, saying that the report didn’t address congressional failures over the crisis. Meanwhile, a group of Democrats is demanding the government immediately reunite the children who are still in custody because of the zero tolerance policy with their families.

There’s Been Few Breakthroughs In Alzheimer’s Drugs In Decades. Where’s The Demand For Progress?

KHN Morning Briefing

In other diseases, loud and outraged patient advocates have played a crucial role in getting experimental treatments and drugs to trial. When it comes to Alzheimer’s, though, experts say there isn’t that energy to push for a cure. In other public health news: cancer and elephants, brain injuries, female doctors, race, Ebola and tainted blood pressure meds.

Some Of Country’s Most Trusted Health Websites Have Outdated, Misleading Information For Pregnant Women

KHN Morning Briefing

From the sites of one of the top-ranked hospitals in the country to Harvard University, ProPublica finds errors and misleading information about preeclampsia, an extremely dangerous condition for pregnant women. ProPublica’s “Lost Mothers” series looks at why the country has such a high maternal mortality rate. In other news on women’s health: pregnancy prevention apps and abortion clinics.

New York Sues Purdue Pharma, Accuses Opioid Maker Of Widespread Fraud

KHN Morning Briefing

New York joins dozens of other states suing the manufacturer of OxyContin. “The opioid epidemic was manufactured by unscrupulous distributors who developed a $400 billion industry pumping human misery into our communities,” Gov. Andrew Cuomo (D-N.Y.) said.

First-In-The-Nation Plan Would Taper Oregon’s Chronic Pain Patients’ Opioid Prescriptions Down To Zero

KHN Morning Briefing

Officials say it’s reducing the patients’ exposure to harmful overprescribing practices, but critics warn that it will cause people to seek out opioids by any means necessary. In other news on the epidemic: the dangers of overdose for postpartum women who have been addicted to opioids; a look at grieving families on the frontlines of the crisis; how the issue could be a winning topic for Democrats; and more.

‘Delay, Deny And Hope You Die’: NFL’s Byzantine Rules Stymie Ex-Players Seeking Health Benefits

KHN Morning Briefing

But Paul Scott, who worked as the NFL’s benefit plan point person, wants to change that. He’s hoping to help former players through the application process to get the disability benefits they’ve earned. Meanwhile, experts find fault in the way the University of Maryland treated football player Jordan McNair when he suffered from heatstroke, which led to his death.